Alexithymia in Parkinson's Disease: A Meta-analysis

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder with diverse motor and non-motor symptoms.
• Alexithymia, characterized by difficulty identifying and expressing emotions, is a recognized non-motor manifestation in PD.
• Previous research has explored alexithymia in PD, but a comprehensive meta-analysis is lacking.

Purpose of the Study:

• To systematically review and meta-analyze the prevalence of alexithymia in Parkinson's disease patients compared to healthy individuals.
• To identify demographic and clinical factors associated with alexithymia in PD.
• To investigate the relationship between alexithymia and depression in PD patients.

Main Methods:

• Systematic review and meta-analysis of 16 observational studies identified through major scientific databases (PubMed, EMBASE, PsycINFO, SCOPUS) published since 2002.
• Random-effects model used for data analysis, including prevalence and correlation meta-analyses.
• Regression analyses were performed to explore factors influencing alexithymia levels, adjusting for covariates.

Main Results:

• Parkinson's disease patients exhibited significantly higher levels of alexithymia compared to the general population (effect size 0.65).
• Significant heterogeneity was observed, partially explained by regional differences, higher levodopa equivalent dosage (positive association), and lower cognitive scores (negative association).
• A pooled correlation revealed a significant association between higher alexithymia and depression scores in PD patients (r = 0.496).

Conclusions:

• Alexithymia is more prevalent in Parkinson's disease patients than in the general population.
• Higher levels of alexithymia in PD are associated with increased depression and higher daily levodopa equivalent dosage.
• Further research is needed to clarify the role of cognitive status and whether alexithymia is a primary feature of PD.